DATA RELEASE: FDA Admits Error over Knee Implants / Contribs from ReGen Biologics to Congressmen Cited
BERKELEY, CA, October 19, 2010--According to an article in the Los Angeles Times, the FDA is admitting to making an error in approving a surgical knee implant called the Menaflex Collagen Scaffold made by Hackensack, N.J.-based ReGen Biologics Inc.
According to the Times, the FDA made the decision to approve the device over the objections of FDA scientists after being pressured by four Democratic Congress members. The article names the members of Congress, all from New Jersey:
A contributions search at MAPLight.org reveals that employees of the company have donated $49,950 to the campaign committees of multiple members of Congress since the 2002 election cycle. Amongst elected members of Congress, the top four recipients of campaign contributions by employees of ReGen Biologics are as follows:
- Sen. Robert Menendez ($16,300)
- Rep. Steven Rothman ($13,300)
- Rep. Frank Pallone ($8,900)
- Sen. Frank Lautenberg ($6,300)
Figures are based on monetary and non-monetary contributions to candidate campaign committees of legislators serving in the 109th, 110th and 111th Congresses for election cycles 2002, 2004, 2006, 2008, 2010. Contributions data provided by the Center for Responsive Politics.
MapLight is a 501(c)(3) nonprofit, nonpartisan research organization that reveals money's influence on politics. If our work has been helpful to you, please consider supporting us.